We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JACS.RT
226
Jackson Acquisition Co II Rights
JACS.RT
$104K 0.02%
372,400
+302,550
+433% +$74.4K
LION icon
227
Lionsgate Studios
LION
$3.53B
$99.3K 0.02%
+17,085
New +$114K
GNT
228
GAMCO Natural Resources, Gold & Income Trust
GNT
$149M
$83.1K 0.01%
13,205
– –
BHC icon
229
Bausch Health
BHC
$2.33B
$67.9K 0.01%
10,200
-500
-5% -$2.57K
CCO icon
230
Clear Channel Outdoor Holdings
CCO
$1.23B
$64.3K 0.01%
55,000
– –
PGACR
231
Pantages Capital Acquisition Corp Right
PGACR
$44.7K 0.01%
+203,200
New +$45K
TBMCR
232
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$41.4K 0.01%
110,950
– –
DDD icon
233
3D Systems Corp
DDD
$633M
$38.5K 0.01%
25,001
– –
RIBBR
234
Ribbon Acquisition Corp Rights
RIBBR
$28.8K ﹤0.01%
+139,200
New +$27.8K
FTW.WS
235
Presidio Production Co Warrants
FTW.WS
$28.2K ﹤0.01%
38,366
– –
COLAR
236
Columbus Acquisition Corp Rights
COLAR
$26.7K ﹤0.01%
144,700
– –
EURKR
237
Eureka Acquisition Corp Right
EURKR
$21K ﹤0.01%
89,200
– –
ESHAR
238
DELISTED
ESH Acquisition Corp Right
ESHAR
$18.6K ﹤0.01%
252,850
– –
GMHS
239
Gamehaus Holdings
GMHS
$45.1M
$18.5K ﹤0.01%
11,440
– –
SVIIR
240
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$18.2K ﹤0.01%
129,700
– –
ASPCR
241
A SPAC III Acquisition Corp Right
ASPCR
$17.5K ﹤0.01%
103,200
– –
CCIXW
242
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
$15.9K ﹤0.01%
16,725
– –
GRML
243
Greenland Mines Ltd
GRML
$31.5M
$11.3K ﹤0.01%
10,000
– –
HSPOR
244
DELISTED
Horizon Space Acquisition I Corp Right
HSPOR
$10.2K ﹤0.01%
67,700
– –
SVIIW
245
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$9.08K ﹤0.01%
64,850
– –
DISTR
246
DELISTED
Distoken Acquisition Corporation Right
DISTR
$9.01K ﹤0.01%
31,050
– –
CLRCR
247
DELISTED
ClimateRock Right
CLRCR
$7.98K ﹤0.01%
69,406
– –
HYAC.WS
248
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$6.98K ﹤0.01%
19,400
– –
CXAIW icon
249
CXApp Inc Warrant
CXAIW
$6.17K ﹤0.01%
83,053
– –
WOLF icon
250
Wolfspeed
WOLF
$1.57B
$3.99K ﹤0.01%
10,000
– –
8 9
10
11 12

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.